Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational StudyPiotr Mieszczański, Janusz Trzebicki, Grzegorz Górniewski et al.|Transplantation Proceedings|2021Cited by 1